Filed under: Brain Health, Stroke Prevention & Care | Tags: AcuteCare Telemedicine, Atlanta healthcare news, atlanta hospitals, atlanta neurology, Dr. Lisa Johnston, healthcare news, hypnotics, insomnia, insomnia hypnotics, insomnia sedatives, Lisa Johnston, medical study, neurologists, northside hospital, risk factors, sedatives, sleep and stroke, sleep and the brain, sleep better, sleep center, sleep disorders, SLEEP journal, sleep study, stroke, stroke care, telemedicine, teleneurology
Insomnia is the most commonly encountered sleep disorder or complaint, with a wide prevalence range reported to be between 10 and 40 percent (the variance is due to differences in the definition of insomnia). Suffice it to say, millions of individuals are affected by insomnia at some point in their lives. Because of the significant increased rate of comorbidity associated with insomnia, the burden placed on society by way of increased utilization of health care resources, poor work performance, and missed work days, it is essential that insomnia is appropriately and efficiently managed.
Individuals who suffer from insomnia frequently seek help from medical professionals and this help is often provided in the form of a sedative/hypnotic medication. Significant risks are associated with the use of sedatives and hypnotics, such as dependency, falls (particularly in the elderly), and even an increase in cancer and death rates, as shown by a recent study. Prescription medications do have a role in the treatment of some individuals with insomnia, as well as those with conditions and situations that may call for temporary use, such as time zone changes and jet lag. However, these medications are often over prescribed and/or misused due to insufficient patient evaluation.
It is well understood that when evaluating a patient with complaints of insomnia, an underlying medical and or psychiatric disorder should be considered. Ruling out and treating underlying etiologies is requisite. With resolution or control of the causative medical or psychiatric condition, the insomnia will often times abate. When thorough evaluations are performed in the setting of insomnia, sedative use can be potentially limited, if not completely avoided.
Complaints of insomnia may also be indicative of another (primary) sleep disorder such as restless leg syndrome (RLS) and periodic limb movements (PLMs), delayed sleep phase disorder (DSPD), or obstructive sleep apnea (OSA). Sleep onset and maintenance difficulties may be the result of both PLMs and OSA. The inability to fall asleep at the desired sleep time will be seen in individuals with DSPD. Patients with the above conditions will frequently complain of daytime sleepiness, a complaint not usually expressed in individuals with primary insomnia. These sleep disorders can all be treated without the use of sedatives. Furthermore, the use of sedatives in these cases will only serve to mask and possibly exacerbate the primary sleep disorder, leading to increased morbidity and mortality rates.
In the July 2010 issue of SLEEP, a study was published showing that the prevalence of sedative use in the general Canadian population had more than doubled between 1994 and 2003. Interestingly, this increase had occurred moreso in men, non-elderly, and obese individuals. The study concluded that “the greater odds of sedative medication use found among morbidly obese men may reflect the presence of underlying obstructive sleep apnea, which may in turn serve to explain in part the known relationship between sedative medications and mortality.” When patients with untreated sleep apnea are prescribed sedative/hypnotic medications, apneic events typically worsen, setting up for poorer outcomes and placing them in danger of respiratory arrest.
When underlying etiologies of insomnia have been ruled out and sedatives are needed, they should be used sparingly and temporarily. When possible, alternative treatment modalities such as cognitive behavioral therapy should be employed to avoid or limit the use of sedative and hypnotic medications.
Filed under: Stroke Prevention & Care | Tags: AcuteCare Telemedicine, atlanta hospital news, atlanta medical news, atlanta medical research, atlanta medicine, atlanta sleep lab, atlanta stroke care, cognition, dementia, Dr. Lisa Johnston, lisa johnston sleep, medical news, medical research, new york times medicine, OSA, OSA cognition, risk factors for stroke, sleep apnea, sleep disorders, stroke prevention, telemedicine atlanta, telemedicine news
Awareness of sleep disorders has increased over the past several years, leading more physicians to appreciate that Obstructive Sleep Apnea (OSA) is an independent risk factor for hypertension, cardiovascular disease and stroke. Although seemingly overlooked, studies as far back as 15 years have also suggested that OSA may be a risk factor for cognitive dysfunction.
When patients present to a neurologist with complaints of cognitive dysfunction, most are screened for potentially reversible causes such as vitamin B12 deficiency, hypothyroidism, undiagnosed/untreated syphilis, or normal pressure hydrocephalus. If all laboratory and imaging studies are normal, these patients are often started on acetylcholinesterase inhibitors, in hopes of slowing down the rate of cognitive decline. Screening for sleep apnea, however, is often times not performed. As a result, the opportunity to treat an otherwise harmful disorder and potentially reverse cognitive impairment is forfeited.
In 2010, an article was published in the New York Times entitled “When Sleep Apnea Masquerades as Dementia.” A case study was reported: “The woman was only in her 60s but complained that she was having trouble concentrating.” She couldn’t follow a television program or stay focused during a conversation. As he evaluated the woman, the physician asked, as he usually does, how she was sleeping. The woman, who lived alone, hadn’t noticed any problems. Her son, however, had stayed with her the previous night to drive her to the appointment. “She was snoring like a freight train,” he reported. Overnight sleep testing determined that the woman had obstructive sleep apnea – nightlong interruptions in breathing that reduce oxygen flow to the brain and prevent deep sleep. The interruptions are quite common in older adults, exacerbating – or sometimes mimicking – dementia symptoms. Treated with a CPAP (continuous positive airway pressure) machine her scores on neuropsychological tests eventually climbed back into normal range.
Another recent study published in JAMA, also showed that sleep disordered breathing may contribute to the development of dementia. 298 women 65 years or older and without dementia were enrolled in this study, undergoing overnight polysomnography testing. Those who were found to have sleep disordered breathing were more likely to have developed cognitive impairment or dementia on follow up testing. It is thought that hypoxemia resulting from sleep disordered breathing is responsible. Dr Michael J. Thorpy, director of the Sleep-Wake Disorders Center at the Montefiore Medical Center in the Bronx, NY stated “We used to think that impaired sleep caused cognitive impairment, but this shows that nocturnal hypoxemia plays an important role and this suggests that the cognitive impairment might be partially reversible in some cases.
Although further studies are needed, these findings do stress the importance of screening patients with complaints of cognitive dysfunction for sleep apnea. Because the large majority of people who develop dementia do so after the age of 65, it would seem imperative to screen younger patients with cognitive complaints for sleep disordered breathing.
Filed under: News | Tags: ACT, acute stroke, AcuteCare Telemedicine, Atlanta, Brand, Dr. James Kiely, Dr. Keith Sanders, Dr. Lisa Johnston, Dr. Matthews Gwynn, Georgia Teleneurology, healthcare, neurology, teleneurology
AcuteCare Telemedicine (ACT), an Atlanta-based healthcare provider specializing in treatment of acute strokes in underserved hospitals, launched a new brand as it gains market share in the industry. AcuteCare, formerly Georgia Teleneurology (GTN), has pursued its mission of providing high-quality emergency neurological care via remote presence to Georgia hospitals lacking 24/7 coverage since September 2009.
The company rebranded in June 2011, officially changing its name to AcuteCare Telemedicine maintaining its uncompromising dedication to deliver the highest quality of neurological care to those it serves. ACT is positioned to become a nationwide leader in the practice of telemedicine.
ACT’s success is largely due to the 4 partners who happen to be board certified neurologists with over 50 years of combined experience. Dr. Matthews Gwynn, Dr. Lisa Johnston, Dr. James Kiely, and Dr. Keith Sanders have a proven track record managing patients with neurological emergencies, particularly acute stroke, via remote presence technology. As a result, ACT has contributed to improved patient outcomes.
“We are excited about the launch of our new brand reflective of our personality,” comments Dr. Kiely. “Our mission and intention is clear. ACT is driving force in the industry, known for quality and commitment to our craft. The rebrand is a component of that.”
As the landscape of medicine continues to evolve, the need for acute neurological care 24 hours a day, 7 days a week, 365 days a year is critical. In addition to increased patient benefit, ACT also provides an opportunity for hospitals to serve acute neurological patients, ultimately impacting revenue growth.
To learn more about ACT, visit www.acutecaretelemed.com.